July 15, 2013 |
Patients at Cancer Treatment Centers of America in Northeast Philadelphia get chauffeured trips to the hospital, often in a limousine. They were recently treated to a performance by a vintage soul group, the Pointer Sisters, and are regularly welcomed with live piano music, fresh organic fare in the cafeteria, and receptionists befitting a classy hotel. These perks are part of the for-profit hospital's strategy to keep patients happy and avoid government penalties. In fact, the center enjoys patient satisfaction numbers among the best of any hospital in the region.
June 16, 2013
Christopher Fifis, Nick Fifis, and John Fifis are the owners of Ponzio's Diner & Bakery Bar in Cherry Hill Growing up as sons of a first-generation Greek immigrant, we learned early about the value of hard work and family. As the owner of Ponzio's Diner in Cherry Hill, our dad spent almost every day for more than two decades greeting guests and entertaining them with his dry wit and sense of humor. We had dinner at the diner almost every night because our dad was always working, and when we were old enough, he put us to work there, too. On the rare occasion that our dad did take time off for a family vacation, we all piled into the car to head to Wildwood for a week, with Greek music turned up as loud as we could stand.
May 9, 2013 |
A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test, which goes on sale Wednesday, joins another one that recently came on the market. Both analyze multiple genes in a biopsy sample and give a score for aggressiveness, similar to tests used now for certain breast and colon cancers. Doctors say tests like these have the potential to curb a major problem in cancer care - overtreatment.
March 2, 2013 |
Nora Situm, the 5-year-old Croatian child seeking an experimental leukemia therapy at Children's Hospital of Philadelphia, has overcome the first obstacle to qualifying for the treatment. Doctors have collected a big enough supply of her T cells, the immune cells that form the basis of the therapy, said Richard Aplenc, Nora's oncologist. The update came in a video statement released Friday by the hospital and Nora's parents - her mother, Giana Atanasovska, and father, Ivica Situm.
February 5, 2013 |
Embracing the promise of personalized medicine, Fox Chase Cancer Center is offering a high-tech DNA test that can identify the genetic mutations driving an individual patient's cancer. Other leading medical centers and biotech firms are launching similar tests, which should help doctors make cancer care more effective and less toxic. Experts say this customized approach will become increasingly important as the arsenal of drugs that target cancer genes grows. For patients at the forefront, however, the value of cutting-edge DNA testing is hard to predict.
October 22, 2012
In a sign of how far the science of cancer genomics has come, the University of Pennsylvania Health System will do genetic tests later this year on cancer cells of all patients with several types of cancer. Penn will test up to 48 genes in patients with melanoma, acute myelogenous leukemia, and brain and lung cancer, said Chi V. Dang, director of the Abramson Cancer Center. The results will reveal which patients could benefit from new drugs that work only for those with certain mutations.
October 4, 2012 |
Revenue growth at area health systems was uneven in the fiscal year ended June 30, with the biggest systems showing strong gains while smaller competitors scraped out, at best, meager increases. Revenues from patients at Holy Redeemer Health System in Meadowbrook, for example, have been nearly flat since 2009. They were $336 million in the year ended June 30. That was $2 million more than in 2009 and $3.5 million less than in 2011. At Montgomery County neighbor Abington Health, patient revenues have been stuck at about $760 million for three years in a row, reflecting a widespread challenge that hospital executives attribute to changing medical-treatment methods and the weak economy.
May 17, 2012 |
Janet Knowles and Kimberly Fisher are breast cancer survivors. The importance of effective treatment is a subject they know intimately, and it's what brought them out Tuesday with Gov. Christie and other political and community leaders to mark the formal groundbreaking for the Cooper Cancer Institute in downtown Camden. The two attribute their survival to Cooper and hope that more patients with all types of cancer will get care with the expansion of the institute to Martin Luther King Boulevard and Haddon Avenue, where work is under way. "It's a special day ... long overdue," said Knowles, a Moorestown resident who contributed $5 million in 2006 to fund the Janet Knowles Breast Cancer Center, headquartered at Cooper University Hospital's Voorhees facility.
December 16, 2011 |
Fox Chase Cancer Center will become part of the Temple University Health System, officials announced Thursday. The combination, which is expected to close next summer, will join two prominent Philadelphia health-care institutions, both of which have faced fiscal difficulties lately. Temple, based in North Philadelphia, will get a nationally recognized research partner that could help it compete with other academic medical centers in the region. Fox Chase, which will keep its name, will get a bigger referral base for patients, room to expand at Temple's Jeanes Hospital next door, and a chance to save money as health-care reform further squeezes the dollars available for clinical care and research.